🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07661433
Recruiting Observational

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

NCT07661433 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2026-06-29
Last updated
2026-07-08

Condition(s) studied

Fetal WeightPregnancyMachine LearningPregnancy - Prenatal Testing

Investigational drug(s) / intervention(s)

AI ultrasound diagnostic tool for fetal weight estimation

AI ultrasound diagnostic tool for fetal weight estimation: Participants will undergo study-specific transabdominal ultrasound acquisition using standardized abdominal sweeps of the gravid abdomen, guided by external maternal landmarks and saved as cineloop videos. The cineloop videos will be analyzed by a locked deep-learning AI diagnostic tool to generate an estimated fetal weight. The AI-generated estimate will be compared with specialist-performed fetal biometry and actual birth weight to evaluate diagnostic accuracy. The AI output is for research evaluation only and will not direct clinical management during the study.

Study summary

Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective diagnostic accuracy study will enroll 1,000 pregnant individuals within one week of anticipated delivery. At a single visit, each participant will undergo two ultrasound assessments: (1) standardized sweeps for AI analysis (performed by both specialist and nonspecialist users), (2) specialist-performed fetal biometry.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years of age or older * Viable intrauterine pregnancy * Delivery expected within one week of study procedures between 24 0/7 and 42 6/7 weeks, including participants with a scheduled induction or cesarean delivery on a known date, or those admitted in spontaneous labor * Ability and willingness to provide written informed consent * Willingness to comply with all study procedures Exclusion Criteria: * Maternal body mass index ≥ 40 kg/m\^2 * Multiple gestation (i.e., twins or higher order) * Known major fetal malformation or anomaly * Any maternal condition (medical, psychological, or social) that, in the opinion of the study team, may interfere with study participation or data integrity.

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Ochsner Health New Orleans Louisiana Not Yet Recruiting
University of North Carolina Chapel Hill North Carolina Recruiting
University of Saskatchewan Saskatoon Saskatchewan Not Yet Recruiting
University of Rwanda Kigali Rwanda Not Yet Recruiting
University Teaching Hospital Lusaka Zambia Not Yet Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07661433 on ClinicalTrials.gov ↗ ← All trials in Canada